新产品上线! Email验证工具 - 限时免费试用中立即试用

外贸营销群发邮件之前,先批量验证邮箱地址是否有效,可节省成本,提高发送成功率,减少被列入黑名单风险。 更多需求:邮箱采集/邮件群发

如果某种物质需要进行协调分类,我是否必须针对附件 VI 第 3 部分条目未涵盖的危险对其进行分类?

问题(中文)
如果某种物质需要进行协调分类,我是否必须针对附件 VI 第 3 部分条目未涵盖的危险对其进行分类?
Question (EN)
If a substance is subject to harmonised classification, do I have to classify it for the hazards which are not covered by the entry in Part 3 of Annex VI?
中文内容由 Google Cloud Translation 自动生成,仅供参考;请以英文原文为准。问答资料来自欧盟化学品管理局(ECHA)官方网站。
答案(中文)
是的,你必须这样做。附件六所列的物质必须根据附件六第三部分中的条目进行分类。此外,此类物质的制造商、进口商或下游用户必须根据标题二,对附件六第三部分条目中未包含统一分类的危险类别或区别进行自我分类。例如,某种物质可能具有急性口服毒性的统一分类,但没有急性皮肤毒性的统一分类。这意味着供应商必须利用现有信息探索是否满足急性皮肤毒性的分类标准,并进行相应的分类。对于涉及水生危害分类急性或慢性第1类的统一分类,如果附件六中没有M因子,则分类员必须设置M因子。对于没有统一分类且根据CLP第8(2)条无法获得充分可靠信息的物理危害,自我分类可能需要进行新的测试。
Answer (EN)
Yes, you do. A substance, which is listed on Annex VI, must be classified in accordance with the entry in Part 3 of Annex VI. Furthermore, the manufacturer, importer or downstream user of such a substance has to carry out a self-classification in accordance with Title II for those hazard classes or differentiations where no harmonised classification is contained in the entry in Part 3 of Annex VI. For example, a substance may have a harmonised classification for acute oral toxicity, but not for acute dermal toxicity. This means that a supplier would have to explore, using the information available, whether the classification criteria for acute dermal toxicity are fulfilled, and classify accordingly. For harmonised classifications referring to the aquatic hazard classification acute or chronic category 1 where no M-factor appears on Annex VI, the classifier must set an M-factor. Self-classification may entail new testing for those physical hazards where no harmonised classification exists and where, pursuant to CLP Article 8(2), adequate and reliable information is not available.